Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCER1B

Journal of Allergy and Clinical Immunology

Volumn 108, Issue 1, 2001, Pages 74-79

  Hizawa, Nobuyuki ^a   Yamaguchi, Etsuro ^a   Jinushi, Eisei ^a   Konno, Satoshi ^a   Kawakami, Yoshikazu ^a   Nishimura, Masaharu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Asthma; Atopy; CTLA4; FCER1B; IgE levels; Promoter polymorphism; Total serum IgE

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR;

ADULT; ALLELE; ARTICLE; ASTHMA; ATOPY; CASE CONTROL STUDY; CONTROLLED STUDY; EXON; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HOMOZYGOTE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR;

EID: 0034916941     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.116119     Document Type: Article

References (37)

1. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production
2. Upregulation of B7.2. but not B7.1, on B cells from patients with allergic asthma
3. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
4. Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells
5. Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma
6. CTLA41g inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma
7. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics
8. A genome-wide search for asthma susceptibility loci in ethnically diverse populations
9. A common FCER1B gene promoter polymorphism influences total serum IgE levels in a Japanese population
10. Direct-writing recorder of the dose-response curves of the airway to methacholine. Clinical application
11. BAY u3405, a thromboxane A2 antagonist, reduces bronchial hyperresponsiveness in asthmatics
12. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups
13. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis
14. Dinucleotide repeat polymorphism at the human CTLA4 gene
15. An Mse I RFLP in the human CTLA4 promotor
16. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population
17. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis
18. The Yin and Yang of T cell costimulation
19. Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population
20. CD28 costimulation accelerates IL-4 receptor sensitivity and IL-4-mediated Th2 differentiation
21. Asthma: From bronchoconstriction to airways inflammation and remodeling
22. Essential role for both CD80 and CD86 costimulation, but not CD40 interactions, in allergen-induced Th2 cytokine production from asthmatic bronchial tissue: Role for αβ, but not γδ. T cells
23. Association of asthma with serum IgE levels and skin-test reactivity to allergens
24. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children
25. How much asthma is really attributable to atopy?
26. Does early exposure to cat or dog protect against later allergy development?
27. Early exposure to house-dust mite and cat allergens and development of childhood asthma: A cohort study
28. The epidemiology and genetics of atopic allergy
29. Immunomodulation by interference with costimulatory molecules: Therapeutic perspectives in asthma
30. Induction and regulation of the IgE response
31. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations
32. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases
33. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis
34. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis
35. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus
36. Common polymorphisms in the CTLA-4 and CD28 genes at 2q33 are not associated with asthma or atopy
37. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma